OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
964756

Wajd Life Trading Co

Medical Equipment, Supplies & DistributionVerified

Wajd Life Trading Co has a return on equity of 18.97%, indicating strong profitability relative to its equity base. The company reports no debt on its balance sheet, as evidenced by a debt-to-equity ratio of 0.0, suggesting a conservative capital structure with no leverage. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability is robust, with a net income of SAR 5,981,470 on revenue of SAR 85,197,760, translating to a net margin of 7.02%. This margin is competitive within the medical equipment and services industry, where operating efficiency and cost control are critical. The return on equity of 18.97% is well above the typical industry median, suggesting effective use of equity capital. Wajd Life Trading Co operates in a single business segment focused on medical devices and facility management services, with no disclosed geographic diversification beyond Saudi Arabia. This concentration increases exposure to local economic and regulatory conditions. The company's revenue is entirely derived from domestic operations, with no material international presence reported. The company's growth trajectory is not quantified in the latest financials, as no prior-year revenue data is provided. However, the absence of debt and strong net margin suggest a stable financial position. The outlook for the next fiscal year is not specified, but the company's current performance indicates a solid foundation for future growth. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the lack of going-concern language in source documents. The dilution risk is currently low, with no difference between basic and diluted shares outstanding. No adjustments have been applied to the valuation metrics, indicating no material dilution events in the recent past. Recent events include the company's continued operations as an agent for international medical device manufacturers, incorporating technology into its service delivery. No recent filings or transcripts have been disclosed that would indicate significant changes in strategy or operations.

30-day price · 9647-1.30 (-21.7%)
Low$4.70High$6.00Close$4.70As of17 May, 00:00 UTC
Profile
CompanyWajd Life Trading Co
Ticker9647.SE
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Wajd Life Trading Co provides medical devices and products services in Saudi Arabia, operating as an agent for international medical device manufacturers and offering operations, maintenance, and facility management services primarily in healthcare and education sectors.

Classification. Wajd Life Trading Co is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Wajd Life Trading Co has a return on equity of 18.97%, indicating strong profitability relative to its equity base. The company reports no debt on its balance sheet, as evidenced by a debt-to-equity ratio of 0.0, suggesting a conservative capital structure with no leverage. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability is robust, with a net income of SAR 5,981,470 on revenue of SAR 85,197,760, translating to a net margin of 7.02%. This margin is competitive within the medical equipment and services industry, where operating efficiency and cost control are critical. The return on equity of 18.97% is well above the typical industry median, suggesting effective use of equity capital. Wajd Life Trading Co operates in a single business segment focused on medical devices and facility management services, with no disclosed geographic diversification beyond Saudi Arabia. This concentration increases exposure to local economic and regulatory conditions. The company's revenue is entirely derived from domestic operations, with no material international presence reported. The company's growth trajectory is not quantified in the latest financials, as no prior-year revenue data is provided. However, the absence of debt and strong net margin suggest a stable financial position. The outlook for the next fiscal year is not specified, but the company's current performance indicates a solid foundation for future growth. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the lack of going-concern language in source documents. The dilution risk is currently low, with no difference between basic and diluted shares outstanding. No adjustments have been applied to the valuation metrics, indicating no material dilution events in the recent past. Recent events include the company's continued operations as an agent for international medical device manufacturers, incorporating technology into its service delivery. No recent filings or transcripts have been disclosed that would indicate significant changes in strategy or operations.
Key takeaways
  • Wajd Life Trading Co has a strong return on equity of 18.97%, indicating efficient use of equity capital.
  • The company maintains a debt-free balance sheet, reducing financial risk.
  • The net margin of 7.02% is competitive within the medical equipment and services industry.
  • The company's operations are concentrated in Saudi Arabia, increasing exposure to local economic and regulatory conditions.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue$85.2M
Gross profit
Operating income
Net income$6.0M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity$31.5M
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity0.0
ROA
ROE19.0%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric9647Activity
Op margin13.3% medp25 5.9% · p75 13.5%
Net margin7.0%8.6% medp25 2.7% · p75 12.7%below median
Gross margin64.0% medp25 60.1% · p75 65.6%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue3.0% medp25 2.7% · p75 4.5%
Debt / equity0.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 07:42 UTC#4770d7a1
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 07:44 UTCJob: 33c66a13